Multikinase inhibitors
What are Multikinase inhibitors?
Multikinase inhibitors work by inhibiting multiple intracellular and cell surface kinases, some of which are implicated in tumor growth and metastatic progression of cancer, thus decreasing tumor growth and replication. Multikinase inhibitors may be used to treat advanced kidney cancer as well as other specific types of cancer.
List of Multikinase inhibitors
View by Generic | Brand
See also
Medical conditions treated or associated with multikinase inhibitors:
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Alopecia
- Anaplastic Large Cell Lymphoma - ALK-Positive
- Biliary Tract Tumor
- Bladder Cancer
- Breast Cancer
- Cholangiocarcinoma
- Chronic Fibrosing Interstitial Lung Disease With A Progressive Phenotype
- Chronic Myelogenous Leukemia
- Colorectal Cancer
- Endometrial Cancer
- Erdheim-Chester Disease
- Follicular Lymphoma
- Gastrointestinal Stromal Tumor
- Graft Versus Host Disease
- Hepatic Tumor
- Hepatocellular Carcinoma
- Histiocytic Neoplasm
- Idiopathic Pulmonary Fibrosis
- Inflammatory Myofibroblastic Tumor
- Low-Grade Glioma
- Marginal Zone Lymphoma
- Melanoma, Metastatic
- Myelofibrosis
- Myeloid/Lymphoid Neoplasms
- Myeloproliferative Disorders
- Neuroendocrine Tumors
- Neurofibromatosis
- Non Small Cell Lung Cancer
- Pancreatic Cancer
- Polycythemia Vera
- Renal Cell Carcinoma
- Solid Tumors
- Systemic Mastocytosis
- Systemic Sclerosis-Associated Interstitial Lung Disease
- Tenosynovial Giant Cell Tumor
- Thyroid Cancer
- Urothelial Carcinoma
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.